These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32858121)

  • 41. G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides.
    Daniel JT; Clark RJ
    Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29144441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fusion proteins as model systems for the analysis of constitutive GPCR activity.
    Schneider EH; Seifert R
    Methods Enzymol; 2010; 485():459-80. PubMed ID: 21050932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probing the mutational landscape of regulators of G protein signaling proteins in cancer.
    DiGiacomo V; Maziarz M; Luebbers A; Norris JM; Laksono P; Garcia-Marcos M
    Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
    Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
    Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elucidation of pathophysiology and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association with the Plasma Membrane Is Sufficient for Potentiating Catalytic Activity of Regulators of G Protein Signaling (RGS) Proteins of the R7 Subfamily.
    Muntean BS; Martemyanov KA
    J Biol Chem; 2016 Mar; 291(13):7195-204. PubMed ID: 26811338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histamine, histamine receptors, and neuropathic pain relief.
    Obara I; Telezhkin V; Alrashdi I; Chazot PL
    Br J Pharmacol; 2020 Feb; 177(3):580-599. PubMed ID: 31046146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neurons.
    Sadeghi M; McArthur JR; Finol-Urdaneta RK; Adams DJ
    Neuropharmacology; 2017 Dec; 127():116-123. PubMed ID: 28533165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting G protein-coupled receptor signalling by blocking G proteins.
    Campbell AP; Smrcka AV
    Nat Rev Drug Discov; 2018 Nov; 17(11):789-803. PubMed ID: 30262890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors.
    Hermans E
    Pharmacol Ther; 2003 Jul; 99(1):25-44. PubMed ID: 12804697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges.
    Fernandes V; Sharma D; Vaidya S; P A S; Guan Y; Kalia K; Tiwari V
    Expert Opin Ther Targets; 2018 Feb; 22(2):131-142. PubMed ID: 29285962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α9-containing nicotinic acetylcholine receptors and the modulation of pain.
    Hone AJ; Servent D; McIntosh JM
    Br J Pharmacol; 2018 Jun; 175(11):1915-1927. PubMed ID: 28662295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors.
    Wang X; Zeng W; Soyombo AA; Tang W; Ross EM; Barnes AP; Milgram SL; Penninger JM; Allen PB; Greengard P; Muallem S
    Nat Cell Biol; 2005 Apr; 7(4):405-11. PubMed ID: 15793568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management.
    Senese NB; Kandasamy R; Kochan KE; Traynor JR
    Front Mol Neurosci; 2020; 13():5. PubMed ID: 32038168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral Neuropathic Pain: From Experimental Models to Potential Therapeutic Targets in Dorsal Root Ganglion Neurons.
    Yeh TY; Luo IW; Hsieh YL; Tseng TJ; Chiang H; Hsieh ST
    Cells; 2020 Dec; 9(12):. PubMed ID: 33371371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roles for Regulator of G Protein Signaling Proteins in Synaptic Signaling and Plasticity.
    Gerber KJ; Squires KE; Hepler JR
    Mol Pharmacol; 2016 Feb; 89(2):273-86. PubMed ID: 26655302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulators of G protein signaling: potential drug targets for controlling cardiovascular and immune function.
    Cho H; Harrison K; Kehrl JH
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):107-18. PubMed ID: 15180451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. G-Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function.
    Tilakaratne N; Sexton PM
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):979-87. PubMed ID: 16405456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of Saponins in the Treatment of Neuropathic Pain.
    Tan B; Wu X; Yu J; Chen Z
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A truncated form of RGS3 negatively regulates G protein-coupled receptor stimulation of adenylyl cyclase and phosphoinositide phospholipase C.
    Chatterjee TK; Eapen AK; Fisher RA
    J Biol Chem; 1997 Jun; 272(24):15481-7. PubMed ID: 9182581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.